Clinical Trials List
2018-12-06 - 2025-12-31
Phase II
Recruiting3
Terminated4
ICD-10C7A.1
Malignant poorly differentiated neuroendocrine tumors
-
Trial Applicant
Efficient Pharma Management Corp.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Chien-Chung Lin Division of Thoracic Medicine
- Wu-Chou Su Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- Ming-Hung Tsai Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Yi-Ping Hung Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Radiology
The Actual Total Number of Participants Enrolled
3 Recruiting
Audit
None
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- 吳峯旭 Division of General Surgery
- 廖苡君 Digestive System Department
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- 滕傑林 Division of Hematology & Oncology
- Tsung -Chih Chen Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- 鄭紹彬 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳教恩 Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- 徐執中 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tai-Jan Chiu Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tsung-Jang Yeh Division of Gastroenterological Surgery
- 李玫萱 Division of Thoracic Medicine
- Hui-Hua Hsiao Division of Hematology & Oncology
- Wang Yao-Kuang Digestive System Department
- Li-Tzong Chen Digestive System Department
- Shih-Chang Chuang Division of Gastroenterological Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
43 participants
-
Global
43 participants
